Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome

Scandinavian Journal of Rheumatology

Volumn 29, Issue 6, 2000, Pages 341-348

  Jonsson, R ^a   Haga, H J ^a   Gordon, T P ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Autoantibodies; Diagnosis; Sj gren's syndrome; Therapy

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; BROMHEXINE; CHLOROQUINE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; METHOTREXATE; MUSCARINIC AGENT; MUSCARINIC M3 RECEPTOR; NANDROLONE DECANOATE; PILOCARPINE; PREDNISONE; QUINUCLIDINE DERIVATIVE; ZIDOVUDINE;

ALGORITHM; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SJOEGREN SYNDROME;

AUTOANTIBODIES; HUMANS; PREVALENCE; RHEUMATOLOGY; SJOGREN'S SYNDROME; WORLD HEALTH;

EID: 0034543806     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097400447525     Document Type: Review

References (82)

1. Sjögren's syndrome
2. Malignant lymphoma in primary Sjögren's syndrome - A multicenter, retrospective, clinical study by the Euorpean concerted action on Sjögren's syndrome
3. Sjögren's syndrome in childhood
4. Dry eyes or mouth. An epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome
5. Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years
6. Prevalence of primary Sjögren's syndrome in an elderly population
7. Sjögren's syndrome. New diagnostic aspects
8. Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community
9. Assessment of the European classification criteria for Sjögren's Syndrome in a series of clinically defined cases: Results of a prospective multicentre study
10. Sjögren's syndrome. Clinical spectrum and current diagnostic controversies
11. A proposal for modification of the European classification criteria for Sjögren's syndrome
12. Sjögren's syndrome
13. Reliability and sensitivity of diagnostic tests for primary Sjögren's syndrome
14. Physiological factors affecting salivary flow rate, oral sugar clearance and the sensation of dry mouth in men
15. Saliva: An additional diagnostic tool in Sjögren's syndrome
16. The European community study group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome
17. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases
18. Salivary histopathology in diagnosis of Sjögren's syndrome
19. Suggested criteria for classification of Sjögren's syndrome
20. Progression of sialoadenitis in Sjögren's syndrome
21. Serum anti-Sjögren's syndrome-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome
22. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome
23. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle
24. Purification of antigenically intact Ro ribonucleoproteins: Biochemical and immunological evidence that the 52-kD protein is not a Ro protein
25. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
26. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd from primary Sjögren's syndrome
27. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus
28. Antibodies to cellular antigens in Sjögren's syndrome
29. Restricted epitope recognition by precipitin-negative anti-La/SS-B-positive sera
30. SS-A(Ro) autoantibodies
31. SS-B(La) autoantibodies
32. Anti-La(SS-B): A diagnostic criterion for Sjögren's syndrome
33. Autoantibodies in Sjögren's syndrome
34. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome
35. Autoantibody synthesis in salivary glands of Sjögren's syndrome patients
36. Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome
37. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome
38. Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome
39. Sjögren's syndrome
40. Occurrence of antibody to salivary duct epithelium in Sjögren's disease, rheumatoid arthritis and other arthritides - A clinical and laboratory study
41. Antibodies to salivary duct cells and other autoantibodies in patients with Sjögren's syndrome and other idiopathic autoimmune diseases
42. Antibodies to AB blood group antigens mimick anti-salivary duct autoantibodies in patients with limited sicca symptoms
43. A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome
44. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome
45. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the α and β type
46. Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome
47. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome
48. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome
49. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome
50. An alternative perspective to the immune response in autoimmune exocrinopathy: Induction of functional quiscence rather than destructive autoaggression
51. Inhibitory effects of muscarinic receptors on parasympathetic neurotransmission in Sjogren's syndrome
52. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome
53. IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome
54. Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation
55. Cryoglobulinaemia in autoimmune rheumatic diseases
56. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive epitopes as predictive factors for the development of lymphoma in primary Sjögren's syndrome
57. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjögren's syndrome
58. Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome
59. Treatment of the patient with Sjögren's syndrome
60. The effect of acupuncture on salivary flow rates in patients with xerostomia
61. Keratoconjunctivitis sicca in patients with primary Sjögren's syndrome. A longitudinal study of ocular parameters
62. The use of oral pilocarpine in xerostomia and Sjögren's syndrome
63. A preliminary study on interferon-alpha treatment for xerostomia of Sjögren's syndrome
64. Treatment of primary Sjögren's syndrome with low-dose natural interferon-α administered by the oral mucosal route: A phase II clinical trial
65. The pharmacological profile of cevimeline: A novel muscarinic agonist for treatment in various models
66. Treatment of primary Sjögren's syndrome with hydroxychloroquine: A retrospective, open-label study
67. Hydroxychloroquine treatment for primary Sjögren's syndrome: A two year double blind crossover trial
68. Prednisone and piroxicam for treatment of primary Sjögren's syndrome
69. Cyclosporin A in primary Sjögren's syndrome. A double blind study
70. Nandrolone decanoate in primary Sjögren's syndrome: A double blind pilot study
71. Methotrexate in primary Sjögren's syndrome
72. Zidovudine in primary Sjögren's syndrome
73. Immunopathogenesis of Sjögren's syndrome: «Facts and fancy»
74. The influence of age on disease manifestations and serological characteristics in primary Sjögren's syndrome
75. Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36
76. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (Sjögren's syndrome) and primary Sjögren's syndrome
77. Primary Sjögren's syndrome in northeast England - A longitudinal study
78. Primary Sjögren's syndrome in the North East of England: A long-term follow-up study
79. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome
80. Plasma immunoglobulin G predicts the long term course of primary Sjögren's syndrome
81. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992
82. Inheritance and immunology in Sjögrens syndrome (in Norwegian)